Contribution of endogenous and exogenous antibodies to clearance of SARS-CoV-2 during convalescent plasma therapy
Maddalena Marconato, Irene A. Abela, Anthony Hauser, Magdalena Schwarzmüller, Rheliana Katzensteiner, Dominique L. Braun, Selina Epp, Annette Audigé, Jacqueline Weber, Peter Rusert, Emèry Schindler, Chloé Pasin, Emily West, Jürg Böni, Verena Kufner, Michael Huber, Maryam Zaheri, Stefan Schmutz, Beat M. Frey, Roger D. Kouyos, Huldrych F. Günthard, Markus G. Manz, Alexandra Trkola
doi: https://doi.org/10.1101/2021.12.09.21267513
Maddalena Marconato
1Department of Medical Oncology and Hematology, University Hospital and University of Zurich and Comprehensive Cancer Center Zurich, Switzerland
Irene A. Abela
2Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland
3Institute of Medical Virology, University of Zurich, Switzerland
Anthony Hauser
2Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland
Magdalena Schwarzmüller
3Institute of Medical Virology, University of Zurich, Switzerland
Rheliana Katzensteiner
2Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland
Dominique L. Braun
2Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland
Selina Epp
3Institute of Medical Virology, University of Zurich, Switzerland
Annette Audigé
3Institute of Medical Virology, University of Zurich, Switzerland
Jacqueline Weber
3Institute of Medical Virology, University of Zurich, Switzerland
Peter Rusert
3Institute of Medical Virology, University of Zurich, Switzerland
Emèry Schindler
4Blood Transfusion Service Zurich, Switzerland
Chloé Pasin
2Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland
3Institute of Medical Virology, University of Zurich, Switzerland
Emily West
2Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland
Jürg Böni
3Institute of Medical Virology, University of Zurich, Switzerland
Verena Kufner
3Institute of Medical Virology, University of Zurich, Switzerland
Michael Huber
3Institute of Medical Virology, University of Zurich, Switzerland
Maryam Zaheri
3Institute of Medical Virology, University of Zurich, Switzerland
Stefan Schmutz
3Institute of Medical Virology, University of Zurich, Switzerland
Beat M. Frey
4Blood Transfusion Service Zurich, Switzerland
Roger D. Kouyos
2Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland
Huldrych F. Günthard
2Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland
3Institute of Medical Virology, University of Zurich, Switzerland
Markus G. Manz
1Department of Medical Oncology and Hematology, University Hospital and University of Zurich and Comprehensive Cancer Center Zurich, Switzerland
Alexandra Trkola
3Institute of Medical Virology, University of Zurich, Switzerland
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted December 11, 2021.
Contribution of endogenous and exogenous antibodies to clearance of SARS-CoV-2 during convalescent plasma therapy
Maddalena Marconato, Irene A. Abela, Anthony Hauser, Magdalena Schwarzmüller, Rheliana Katzensteiner, Dominique L. Braun, Selina Epp, Annette Audigé, Jacqueline Weber, Peter Rusert, Emèry Schindler, Chloé Pasin, Emily West, Jürg Böni, Verena Kufner, Michael Huber, Maryam Zaheri, Stefan Schmutz, Beat M. Frey, Roger D. Kouyos, Huldrych F. Günthard, Markus G. Manz, Alexandra Trkola
medRxiv 2021.12.09.21267513; doi: https://doi.org/10.1101/2021.12.09.21267513
Contribution of endogenous and exogenous antibodies to clearance of SARS-CoV-2 during convalescent plasma therapy
Maddalena Marconato, Irene A. Abela, Anthony Hauser, Magdalena Schwarzmüller, Rheliana Katzensteiner, Dominique L. Braun, Selina Epp, Annette Audigé, Jacqueline Weber, Peter Rusert, Emèry Schindler, Chloé Pasin, Emily West, Jürg Böni, Verena Kufner, Michael Huber, Maryam Zaheri, Stefan Schmutz, Beat M. Frey, Roger D. Kouyos, Huldrych F. Günthard, Markus G. Manz, Alexandra Trkola
medRxiv 2021.12.09.21267513; doi: https://doi.org/10.1101/2021.12.09.21267513
Subject Area
Subject Areas
- Addiction Medicine (403)
- Allergy and Immunology (712)
- Anesthesia (207)
- Cardiovascular Medicine (2969)
- Dermatology (253)
- Emergency Medicine (445)
- Epidemiology (12806)
- Forensic Medicine (12)
- Gastroenterology (830)
- Genetic and Genomic Medicine (4621)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2941)
- Health Policy (1073)
- Hematology (393)
- HIV/AIDS (932)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (475)
- Neurology (4408)
- Nursing (238)
- Nutrition (649)
- Oncology (2295)
- Ophthalmology (652)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (281)
- Palliative Medicine (84)
- Pathology (502)
- Pediatrics (1200)
- Primary Care Research (502)
- Public and Global Health (7004)
- Radiology and Imaging (1544)
- Respiratory Medicine (921)
- Rheumatology (444)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)